Upstream Bio, Inc. (UPB)
7.18
+0.57
(+8.62%)
USD |
NASDAQ |
Aug 25, 16:00
7.18
0.00 (0.00%)
After-Hours: 19:59
Upstream Bio Market Cap : 393.26M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 362.04M |
| August 21, 2026 | 381.75M |
| August 20, 2026 | 375.18M |
| August 19, 2026 | 411.60M |
| August 18, 2026 | 375.18M |
| August 17, 2026 | 391.06M |
| August 14, 2026 | 387.23M |
| August 13, 2026 | 378.47M |
| August 12, 2026 | 378.47M |
| August 11, 2026 | 388.33M |
| August 10, 2026 | 407.50M |
| August 07, 2026 | 397.09M |
| August 06, 2026 | 376.28M |
| August 05, 2026 | 366.79M |
| August 04, 2026 | 369.51M |
| August 03, 2026 | 349.38M |
| July 31, 2026 | 343.39M |
| July 30, 2026 | 357.54M |
| July 29, 2026 | 348.83M |
| July 28, 2026 | 348.29M |
| July 27, 2026 | 348.29M |
| July 24, 2026 | 348.83M |
| July 23, 2026 | 348.29M |
| July 22, 2026 | 358.63M |
| July 21, 2026 | 379.85M |
| Date | Value |
|---|---|
| July 20, 2026 | 379.85M |
| July 17, 2026 | 381.48M |
| July 16, 2026 | 393.46M |
| July 15, 2026 | 395.63M |
| July 14, 2026 | 388.56M |
| July 13, 2026 | 396.18M |
| July 10, 2026 | 409.78M |
| July 09, 2026 | 425.02M |
| July 08, 2026 | 434.27M |
| July 07, 2026 | 427.74M |
| July 06, 2026 | 402.71M |
| July 02, 2026 | 408.69M |
| July 01, 2026 | 396.18M |
| June 30, 2026 | 376.59M |
| June 29, 2026 | 377.13M |
| June 26, 2026 | 367.34M |
| June 25, 2026 | 346.11M |
| June 24, 2026 | 345.57M |
| June 23, 2026 | 343.93M |
| June 22, 2026 | 342.85M |
| June 18, 2026 | 340.12M |
| June 17, 2026 | 334.68M |
| June 16, 2026 | 322.17M |
| June 15, 2026 | 331.96M |
| June 12, 2026 | 331.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sutro Biopharma, Inc. | 354.56M |
| Compass Therapeutics, Inc. | 453.82M |
| ACADIA Pharmaceuticals, Inc. | 5.264B |
| Alnylam Pharmaceuticals, Inc. | 32.09B |
| Anika Therapeutics, Inc. | 288.00M |
Market Cap Related Metrics
| PS Ratio | 123.38 |
| PEG Ratio | -0.0610 |
| Price to Book Value | 1.451 |
| Price | 7.18 |
| Earnings Yield | -40.20% |
| PEGY Ratio | -0.0610 |